Johnson & Johnson allocations on hold, May 17

Johnson & Johnson COVID-19 vaccine allocations being provided to state, local and territorial jurisdictions, and other partners, have been put on hold pending the U.S. Food and Drug Administration certification of doses produced at the Baltimore Emergent plant. All currently allocated doses of the Johnson & Johnson vaccine distributed are safe and have been cleared for use. The proportion of the Johnson & Johnson vaccine on hold represents a small portion of vaccines allocated in Oregon. There are sufficient doses of Moderna and Pfizer to ensure providers can continue delivering doses statewide, at events and other locations administering the vaccines.